罗氏制药在华产品

根据国家食品药品监督管理局令第24号公布的《药品说明书和标签管理规定》,药品说明书获准修改后,药品生产企业应当将修改的内容立即通知相关药品经营企业、使用单位及其他部门。为使相关单位和医药卫生专业人士及时获得最新说明书信息,我司按该规定要求公布最新批准的说明书信息。

Actemra (Tocilizumab)

Healthcare Professional Guide & Dosing Guide

Healthcare Professional Brochure

To assist healthcare professionals in assessing the benefits and risks associated with ACTEMRA therapy in patients.

Actemra Dosing Guide

A guide to assist healthcare professionals with the dose preparation and administration of ACTEMRA therapy in patients.

Patient Guides

Patient Brochure

This brochure provides key information to assist in the patient‘s understanding of the benefits and risks associated with ACTEMRA therapy

Actemra Patient Alert Card

This patient alert card contains important safety information that patients need to be aware of before, during and after treatment with ACTEMRA.

病人指引

病人小冊子

本病人小冊子提供有關使用雅美羅ACTEMRA的療效和風險

病人資訊卡

此卡提供在 雅美羅 ACTEMRA 療程期間及療程前後需注意的重要安全資訊

Columvi (Glofitmab)

Healthcare Professional Brochure

HCP Brochure

HCP brochure containing important safety information to minimize the risk of tumour flare and a reminder of the Patient Card.

Enspryng (Satralizumab)

Enspryng Patient Alert Cards / 病人資料卡

Patient Alert Card (English)

Patient Alert Card containing important safety information for patients

新测试

子标题有

速福达

1111

111

222

子标题22

333

444